Paed and adolescent gynaecologist Flashcards
Hormone changes for normal puberty
Pulsatile secretion of GnRH, initially occurs at night time only, then progresses to daytime secretion
During this time levels of LH and FSH, increase in pulsatility and amplitude
Pulses then stimulate a rise in estradiol levels
Normal puberty begins:
- 8-12y in girls - 9-14y in boys
Briefly describe Tanner stages
I - pre-puberty
II - buds, few hairs
V - fully formed and adult shape pubic hair, extends to thighs
Define Precocious puberty
Incidence
Usually as the development of secondary sexual characteristics before age 8 in girls, 9 in boys
Or the onset of periods before age 9 in girls
2%
Causes of precocious puberty
CENTRAL - more common. Sequential development - growth, breasts, pubic hair, then menarche
- Idiopathic (80%)
- Destruction from tumour or SOL
- Excessive pressure e.g. hydrocephalus
- Meningitis
- Head injury
- Irradation
- Neurofibromatosis type 1
PERIPHERAL - relatively uncommon in girls, always pathological
- Granulosa cell tumour (oestrogen)
- Androgen secreting tumour - sertoli-leydig tumour
- Exogenous sex steroids
- McCune Albright syndrome
McCune Albright syndrome
Triad of fibrous dysplasia of bone (abnormal bone cysts), café au lait spots and endocrinopathies especially GnRH independent precocious pseudopuberty
Rx: suppression of gonadal steroidogenesis with aromatase inhibitors
History features for precocious puberty
Age of onset, sequence and progression of pubertal changes
FHx: pubertal onset of parents and siblings
Linear growth acceleration
Neurological symptoms
Behavioural changes
Abdominal pain or bloating
- Suggestive of ovarian tumour or cyst
Previous Hx CNS disease
History of exposure to exogenous sex steroids
- E.g. to treat severe asthma
History of trauma
Exam for precocious puberty
Height, weight BMI Skin exam - any café au lait spots Pubertal Tanner staging Neurological exam Abdominal exam Examination of external genitalia Signs of virilisation - clitoromegaly, deepening of voice, hirsutism
Ix for precocious puberty
Hormone profile - LH, FSH, E2, testosterone
Adrenal steroids
- DHEAs
- 17-OH progesterone
- Androstenedione
TFTs, free thyroxine
Prolactin
- May be raised in chronic hypothyroidism, McCune-Albright syndrome, prolactinomas, or pituitary stalk compression
Pelvic and abdominal US
Left wrist X-ray - bone age
Directed imaging
- CT/MRI brain, adrenals
Consequences of precocious puberty
Short adult stature due to premature epiphyseal closure
Psychosocial problems
- Pubertal levels of sex steroids --> adolescent behaviour - Altered self image - Girls are at increased risk of sexual abuse and early pregnancy
Treatment of precocious puberty
Goal of treatment:
- Halt or cause regression of secondary sexual characteristics
- Prevent early menarche
- Retard skeletal maturation and improve final height
- Avoid psychosocial / behavioural sequelae
Paediatric endocrinologist
Central idiopathic precocious puberty
- GnRH analogues - suppress natural GnRH production - Continue until 10-11y
3-6 monthly clinical assessment
Annual bone density assessment
Peripheral
- Surgery
- remove oestrogen exposure
Definition of delayed puberty
Absence of breast development by age 13
Or no menarche by 3y after breast development (or age 16)
Aetiology of delayed puberty
Hypogonadotropic hypogonadism
- Central defect - no pituitary or hypothalamic stimulation of the gonad and low FSH
Constitutional delay – often familial pattern
Chronic illness e.g. diabetes, CF, renal failure
Anorexia nervosa
Hydrocephalus or CNS tumours
Kallmans Syndrome
Hypergonadotropic hypogonadism No functioning gonads, high FSH Abnormal gonadal development Turner Syndrome Following Chemotherapy or Radiotherapy Galactosaemia
Genital bleeding in childhood - differentials
Vulvovaginitis Foreign body Genital trauma - Inadvertent or deliberate Neoplasm Neonatal estrogen withdrawal bleed Premature menarche or precocious puberty Urethral prolapse UTI Labial adhesions Dermopathy - Contact / allergic, dermatitis, lichen sclerosis, eczema, psoriasis Pinworms with excoriation
Vulvovaginitis
- Pathogenesis
Children lack the protection that women have
- Lack of vaginal oestrogen (skin is therefore thin and delicate)
- Lack of labial hair and fat pads
Proximity of anus
Other contributing factors can include:
- Poor perineal hygiene
- Chemical irritation due to bubble baths and detergents
Treatment of vulvovaginitis
Information (written) Reassure Improved hygiene - Wipe from front to back - Avoid soaps / bubble baths - Urinating with knees apart - Cotton underwear
Barrier creams or emollients
Children nearly always grow out of it by puberty
Probiotics
Labial adhesions / fusion
Incidence
Up to 3.3% of pre-pubertal girls
Peak incidence is in the first year of life
Never present at birth
Likely from lack of oestrogen
Treatment of labial adhesion
Reassure await resolution
Avoid traction, oestrogen, steroids
Topical oestrogen if urinary symptoms
- Short course, 6 weeks (max)
Primary vs. secondary dysmenorrhoea
Primary = menstrual pain in the absence of any organic cause, which occurs within the first three years of menarche
- often crampy
Secondary = crampy pain a/w menses due to organic disease - e.g. endo, adenomyosis, adhesive disease, outflow tract obstruction
Associated symptoms of primary dysmenorrhoea
- N/v
- Fatigue or weakness
- Changes in bowel movements
- Backache
- Headache
- Breast tenderness
- Dizziness
Significant impact on QoL
- Absenteeism, academic performance, social activities, difficultly concentrating, mood
Pathophysiology of primary dysmenorrhoea
Multifactorial
- Excess prostaglandin production –> uterine contractions
- Narrow cervix
- Retrograde menstruation
Management of primary dysmenorrhoea
Consider 3/12 course of NSAIDs prior to investigations (e.g. Ponstan / mefenamic acid 500mg TDS, day prior to period starting)
NSAIDs - ibuprofen, mefanamic acid, naproxen
- Reduces volume of menstrual flow if started at onset of bleeding and taken at appropriate dose and frequency
- Inhibit COX 1/2 enzymes –> reduced PG and thromboxane production
Cochrane 2015
- Significantly more effective than placebo in relieving pain
- Differences between NSAIDs not shown
- Adverse events with NSAIDs only slightly raised
COCP containing levonorgestrel
- Reduce menstrual flow and pain by 50%
TXA - Reduces flow, less bleeding = less pain
Progesterone oral therapy - cyclical provera
Mirena IUS
Self-care / alternative therapies
Primary amenorrhoea
definition and incidence
Primary amenorrhoea is rare - 0.3%
Defined as the absence of menses at age 16 in the presence of normal growth and secondary sexual characteristics
Or if 14y with no secondary sexual characteristics
Causes of primary amenorrhoea
ANOMALIES OF OUTFLOW TRACT - 20%, normal FSH and E2
Imperforate hymen
Transvaginal septum
Mullerian dysgenesis (MRKH syndrome)
Complete androgen insensitivity syndrome
PRIMARY OVARIAN INSUFFICIENCY - 40%, high FSH, low E2
Chromosomal abnormalities - turner, Swyer, 46 XX (pure gonadal dysgenesis)
Single gene mutation - fragile X
Autoimmune disorders
Injury - mumps, chemo
CENTRAL - 35%, low FSH and E2 Weight loss / anorexia Idiopathic hypogonadotrophic hypogonadism Tumour Hyperprolactinaemia
OTHER ENDOCRINE
PCOS
Thyroid
Investigations of primary amenorrhoea
Bloods
- HCG
- FSH, LH, oestradiol, 17-OH progesterone, prolactin, TFT, testosterone, DHEA, SHBG,
Karyotype
Abdominal / pelvic US
○ Uterus absent or abnormal –> karyotype
- 46, XY –> androgen insensitivity syndrome
- 46, XX –> Mullerian agenesis
+/- MRI
Bone age
Idiopathic hypogonadotropic hypogonadism
causing primary amenorrhoea
Genetic disorders that affect the production and/or action of GnRH, resulting in reduced serum levels of sex steroids
Have normal ovaries
In females, onset of adrenarche with absent of thelarche and menarche
- Pubertal induction for breast development and uterine growth with oestradiol
- Maintenance of normal menstrual cycle and bone health with COCP
- Pregnancy can be achieved in patients who have received and responded to treatment
Weight / exercise related
causing primary amenorrhoea
Reduced fat cells –> no leptin –> informing the hypothalamus that not well fed enough to reproduce –> reduced FSH/LH –> low oestradiol
In order to normalised pubertal development and optimise growth, calorie intake and energy expenditure should be adjusted
Estrogen therapy and current bone age assessment may be considered
Optimise vitamin D and calcium